MedPath

Study of the ability of a test measuring the clotting capacity of the blood to predict need of multiple transfusions during liver transplant surgeries

Not Applicable
Conditions
Health Condition 1: K70-K77- Diseases of liver
Registration Number
CTRI/2024/02/062266
Lead Sponsor
Dr Rela Institute and Medical Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

To assess whether pre-operative maximum clot firmness value of the ROTEM graph can predict incidence of massive transfusion in patients undergoing liver transplant surgeries.

Exclusion Criteria

1. Patient refusal

2. Patients undergoing combined liver kidney transplants

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A deranged maximum clot firmness value will predict the incidence of massive blood transfusion in patients undergoing liver transplant surgery.Timepoint: Pre-operative day <br/ ><br>Post-operative day 0 or day of surgery
Secondary Outcome Measures
NameTimeMethod
1. Association of deranged MCF value on ROTEM with early allograft dysfunction <br/ ><br>2. Association of deranged MCF on ROTEM with incidence of AKI <br/ ><br>3. Association of deranged MCF on ROTEM with increased mortality <br/ ><br>4. Association of deranged MCF on ROTEM with sepsisTimepoint: Pre-operative day <br/ ><br>Post-operative day 1 through Post-operative day 7
© Copyright 2025. All Rights Reserved by MedPath